Janux Therapeutics, Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+824K	90%	$30.75	+$25.3M
Sells	2	-91.7K	10%	$49.06	-$4.5M
Net	-1	+732K	80%		+$20.8M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Avalon Ventures XI, L.P.	10%+ Owner	$347M			Oct 16, 2024
Jay Lichter	10%+ Owner	$294M			Sep 13, 2024
Tighe Reardon	Acting Chief Financial Officer	$227M			Jun 3, 2024
Bregua Corp	10%+ Owner	$22M			Jun 15, 2021
David Alan Campbell	President and CEO, Director	$17.6M	-$2.71M	-13.4%	Jan 7, 2025
Thomas DiRaimondo	Chief Scientific Officer	$7.44M			Jan 2, 2025
Charles M. Winter	Chief Technical Officer	$4.43M			Jan 2, 2025
Sheila Gujrathi	Director	$3.04M			Jun 11, 2025
Andrew Hollman Meyer	Chief Business Officer	$2.55M	-$1.79M	-41.2%	Nov 14, 2025
Vickie L. Capps	Director	$1.89M			Jun 11, 2025
Byron Robinson	Chief Strategy Officer	$1.61M			Jan 2, 2025
Zachariah McIver	Chief Medical Officer	$1.49M			Jan 2, 2025
Orbimed Advisors Llc	Director	$1.36M			Dec 29, 2021
Peter A. Thompson	Director	$1.36M			Jun 14, 2022
Janeen Noel Doyle	Chief Corp. & Bus. Dev. Ofcr	$1.01M			Jun 2, 2025
Maria Dobek	Vice President, Accounting	$803K			Jan 2, 2025
Eric Dobmeier	Director	$255K			Jun 11, 2025
Natasha Hernday	Director	$223K			Jun 11, 2025
Ronald W. Barrett	Director	$160K			Jun 11, 2025
Winston Kung	Director	$160K			Jun 11, 2025
Jake Simson	Director	$160K			Jun 11, 2025
Alana B. McNulty	Director	$160K			Jun 11, 2025
Ra Capital Management, L.P.	Director, 10%+ Owner	$160K	+$25.3M		Jun 11, 2025
Shahram Salek-Ardakani	Chief Scientific Officer				Jan 3, 2022
Stefan Heller	Director				Jun 14, 2022
Wayne Godfrey	Chief Medical Officer				Jan 3, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.